204 related articles for article (PubMed ID: 11187951)
1. Aspirin for primary prevention. Doctors and patients should understand potential benefits and risks of aspirin treatment.
Alkhenizan A
BMJ; 2000 Dec; 321(7274):1472-3. PubMed ID: 11187951
[No Abstract] [Full Text] [Related]
2. [After the disappointing ASS primary prevention trial. "Holding back in women"].
Rupprecht HJ
MMW Fortschr Med; 2005 Mar; 147(12):13. PubMed ID: 15832783
[No Abstract] [Full Text] [Related]
3. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
Bartolucci AA; Howard G
Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
[TBL] [Abstract][Full Text] [Related]
4. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R
Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and the risk of hemorrhagic stroke.
Rosenberg R
J Fam Pract; 1999 Mar; 48(3):169-70. PubMed ID: 10086752
[No Abstract] [Full Text] [Related]
6. [The role of aspirin in the primary prevention of cardiovascular disease].
Rodondi N; Cornuz J
Rev Med Suisse; 2006 Mar; 2(56):646-51. PubMed ID: 16597054
[TBL] [Abstract][Full Text] [Related]
7. Aspirin for primary prevention of myocardial infarction: what is the evidence?
Kappagoda T; Amsterdam E
J Cardiopulm Rehabil Prev; 2012; 32(1):1-8. PubMed ID: 21946421
[TBL] [Abstract][Full Text] [Related]
8. An update on aspirin in the primary prevention of cardiovascular disease.
Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
[TBL] [Abstract][Full Text] [Related]
9. [Clinical studies of the effectiveness of aspirin in the prevention of major cardio-cerebrovascular occurrences].
Mariani M; Biadi O
Cardiologia; 1995 Dec; 40(12 Suppl 1):423-8. PubMed ID: 8998750
[No Abstract] [Full Text] [Related]
10. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
11. Aspirin for the primary prevention of coronary events.
Mascitelli L; Pezzetta F
N Engl J Med; 2002 Sep; 347(12):948; author reply 948. PubMed ID: 12240692
[No Abstract] [Full Text] [Related]
12. [Female, young, healthy. ASS does not protect from myocardial infarct].
MMW Fortschr Med; 2005 Mar; 147(12):10. PubMed ID: 15832782
[No Abstract] [Full Text] [Related]
13. Aspirin for primary prevention of cardiovascular disease (revisited).
Med Lett Drugs Ther; 2006 Jul; 48(1238):53. PubMed ID: 16841021
[No Abstract] [Full Text] [Related]
14. Aspirin for prevention of myocardial infarction.
Mirvis DM
J Tenn Med Assoc; 1995 Oct; 88(10):392-4. PubMed ID: 7475013
[No Abstract] [Full Text] [Related]
15. [Primary prevention of cardiovascular diseases with acetylsalicylic acid].
Waltering A; Hemkens L; Florack C
Dtsch Med Wochenschr; 2005 Dec; 130(49):2847-52. PubMed ID: 16317615
[TBL] [Abstract][Full Text] [Related]
16. Aspirin for the primary prevention of cardiovascular events.
Ferrini R; Clark B
Am Fam Physician; 2002 Nov; 66(9):1737-8. PubMed ID: 12449273
[No Abstract] [Full Text] [Related]
17. Clinical practice. Aspirin for primary prevention of coronary events.
Lauer MS
N Engl J Med; 2002 May; 346(19):1468-74. PubMed ID: 12000818
[No Abstract] [Full Text] [Related]
18. Clopidogrel: new indication. In combination with aspirin: marginal additional benefits.
Prescrire Int; 2007 Aug; 16(90):146. PubMed ID: 17724837
[TBL] [Abstract][Full Text] [Related]
19. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
20. [Primary prevention of coronary thrombosis by antithrombotic agents].
Milon H; Lantelme P; Khettab F; Mestre-Fernandes C; Lasserre-Remy S
Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1243-50. PubMed ID: 11794965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
